Connor, Clark & Lunn Investment Management (CC&L)’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-1,713
| Closed | -$43K | – | 1050 |
|
|
2016
Q3 | $43K | Sell |
1,713
-5,508
| -76% | -$138K | ﹤0.01% | 806 |
|
|
2016
Q2 | $178K | Sell |
7,221
-7,278
| -50% | -$179K | ﹤0.01% | 756 |
|
|
2016
Q1 | $420K | Sell |
14,499
-1,275
| -8% | -$36.9K | ﹤0.01% | 597 |
|
|
2015
Q4 | $586K | Buy |
15,774
+575
| +4% | +$21.4K | ﹤0.01% | 520 |
|
|
2015
Q3 | $740K | Sell |
15,199
-3,564
| -19% | -$174K | 0.01% | 454 |
|
|
2015
Q2 | $1.29M | Buy |
18,763
+3,525
| +23% | +$243K | 0.01% | 298 |
|
|
2015
Q1 | $545K | Buy |
+15,238
| New | +$545K | ﹤0.01% | 383 |
|